Novelix Pharmaceuticals Limited (BOM:536565)

India · Delayed Price · Currency is INR

80.21

+0.60 (0.75%)

At close: Jun 23, 2026

173.47% (1Y)

Market Cap	1.63B +515.3%
Revenue (ttm)	1.32B +330.6%
Net Income	25.57M +2,924.8%
EPS	1.21 +1,244.4%
Shares Out	21.09M
PE Ratio	63.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,197
Open	79.61
Previous Close	79.61
Day's Range	79.61 - 83.49
52-Week Range	29.33 - 92.00
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Novelix Pharmaceuticals

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India. [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 1994

Employees 8

Stock Exchange Bombay Stock Exchange

Ticker Symbol 536565

Full Company Profile

Financial Performance

In fiscal year 2026, Novelix Pharmaceuticals's revenue was 1.32 billion, an increase of 330.60% compared to the previous year's 307.33 million. Earnings were 25.57 million, an increase of 2924.85%.

Financial Statements